LECTRUM

This brand name is authorized in Brazil, Ecuador

Active ingredients

The drug LECTRUM contains one active pharmaceutical ingredient (API):

1 Leuprorelin UNII 37JNS02E7V - LEUPROLIDE ACETATE

Leuprorelin is inactive when given orally due to poor membrane permeability and an almost complete inactivation by intestinal proteolytic enzymes. Leuprorelin has potent LHRH agonist properties when given during short-term and intermittent therapy, however, when administered in a continuous, nonpulsatile manner, LHRH analogs induce inhibition of gonadotropin secretion and suppression of testicular steroidogenesis. Read about Leuprorelin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LECTRUM Powder for suspension for injection	Marketing Authorisation Holder	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L02AE02	Leuprorelin	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AE Gonadotropin releasing hormone analogues
Discover more medicines within L02AE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 511513501158415, 511513502154413
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 392-MEE-0714, H-M48-10-02, H-M49-10-02